MAPK3 and hepatocellular carcinoma: Studies by Chen et al. have shown that HJURP unstable p21 through MAPK/ERK1/2 and AKT/GSK3 beta signaling pathways, thereby promoting hepatocellular carcinoma proliferation [39].